What caused the 4512.T stock volume spike today?

Today’s spike in 4512.T stock came from concentrated buying and retail interest. Volume was **383,200** versus average **56,026**, without a direct company release. Traders moved on momentum ahead of the next earnings date on **13 May 2026**.

Is 4512.T stock fairly valued right now?

Valuation is mixed. 4512.T stock trades at a high trailing PE of **163.94**, but a P/B near **1.02**. That suggests market prices factor in low current earnings versus book value. Compare to healthcare peers before deciding.

What is Meyka AI’s short-term forecast for 4512.T stock?

Meyka AI's forecast model lists a quarterly target of **365.58 JPY** and a monthly figure of **400.11 JPY**. The quarterly target implies about **10.78%** upside from **330.00 JPY**. These are model projections, not guarantees.

How should traders manage risk after the volume spike in 4512.T stock?

For 4512.T stock use tight intraday stops and monitor volume for follow-through. Watch RSI above **75** as a potential reversal signal. Size positions small due to elevated PE and retail-driven volatility.

JP Stocks

4512.T Wakamoto Pharmaceutical JPX 06 Feb 2026: volume 383,200 signals momentum

ByDanny Kontos February 6, 2026February 6, 2026

We saw a clear intraday volume spike in 4512.T stock as Wakamoto Pharmaceutical (JPX) jumped to 330.00 JPY, up 20.00 JPY (6.45%), on 06 Feb 2026. Trading volume reached 383,200 shares versus an average of 56,026, giving a relative volume of 37.25. We flag this as a volume-driven momentum move that traders can monitor for follow-through or quick profit-taking.